InVivo names new CFO as shares sputter; InspireMD watches sales slide;

@FierceMedDev: ICYMI yesterday: Special Report: 'Big' med tech M&A deals getting smaller. Feature | Follow @FierceMedDev

@DamianFierce: Feisty company says Covidien willfully violated its patents, sues for injunction and cash. Story | Follow @DamianFierce

@MarkHFierce: Doctor-owned MRI facilities may be overused, a new study concludes. Article | Follow @MarkHFierce

@MichaelGFierce: Special report from FierceDrugDelivery: The race for the artificial pancreas. Report | Follow @MichaelGFierce

> Boston's InspireMD ($NSPR), a developer of embolic protection stents, blamed restructuring and refinancing for a drop in revenue and a jump in net losses during fiscal 2013. Item

> InVivo Therapeutics ($NVIV) has appointed an interim CFO after last week's unexpected resignation sent its shares downward. News

> Doctors are making unnecessary referrals for orthopedic knee-imaging tests at MRI facilities in which they have a financial interest, driving up healthcare costs. Article

> Famed MIT med tech inventor Robert Langer is slated to receive the prestigious BioMed SA 2013 Julio Palmaz Award for Innovation in Healthcare and the Biosciences. Item

> Kips Bay Medical ($KIPS) said that the Emory Heart and Vascular Center in Atlanta performed the first implant of the company's eSVS Mesh as an external saphenous vein graft support device. The surgery is part of an ongoing U.S. clinical trial. Item

> VeriTeQ has filed two new patents with the U.S. Patent and Trademark Office involving technology used for breast implant manufacturing. Item

Biotech News

@FierceBiotech: Next FierceBiotech Event: 'Big Data Gets Smart.' More | Register | Follow @FierceBiotech

@JohnCFierce: In case you missed it, this is why ChemoCentryx got back the rights to vercirnon. Article | Follow @JohnCFierce

@EmilyMFierce: CDC Threat Report: Yes, Agricultural Antibiotics Play a Role in Drug Resistance. Wired report | Follow @EmilyMFierce

> Aerie Pharma jumps into IPO game with $58M pitch to investors. News

> Can AstraZeneca change a narrative of R&D retreat and defeat? More

> Report: Clovis looks to cash in on the bull market for biotechs. Article

Pharma News

@FiercePharma: Aging population to fuel big leap in cancer cases--and drug sales. Can research keep up? ICYMI yesterday | Follow @FiercePharma

@EricPFierce: FDA warning letter for Stride's Agila plant was overshadowed by Ranbaxy's news of third import alert. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Reps making fewer hospital visits; one tells Reuters the work lull has him "spending more time drinking tea and worrying about redundancy." | Follow @CarlyHFierce

> U.K. gatekeepers unsure Sanofi's MS drug Aubagio worth the price. Story

> GlaxoSmithKline weighs RBS chair to replace board chief Gent. Report

Biomarkers News

> Study: Change in breast cancer biomarker indicates recurrence-free survival. More

> 'Better' lung cancer biomarker could aid early detection. More

> 12-year study flags new biomarker for high risk of diabetes. Story

> Three-gene biomarker could detect aggressive prostate cancer sooner. Article

> RAS mutations predict lack of response to Vectibix. Item

Drug Delivery News

> Drug delivery patch mimics adhesion used by beetles. More

> Mystic scores two platform patents for intraocular, intranasal delivery. Article

> Veritas wins European patent for RNA delivery method. Item

> Profectus begins PhI HIV vax trial with 'prime-boost' delivery. Story

> Microbottles with dissolving 'corks' deliver drugs in higher temps. Report

Diagnostics News

> Medicare Dx payment reform tackled in U.S. House bill. Article

> Adaptive Biotechnologies wins NIH backing for immune system Dx test. Story

> Doctors may be overusing MRI facilities they own. Report

> Canadian startup's analyzer could upend HIV, cancer Dx testing. Article

> International team builds 2 rapid tests for malaria treatment resistance. More

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.